AU2002349727A1 - Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof - Google Patents
Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereofInfo
- Publication number
- AU2002349727A1 AU2002349727A1 AU2002349727A AU2002349727A AU2002349727A1 AU 2002349727 A1 AU2002349727 A1 AU 2002349727A1 AU 2002349727 A AU2002349727 A AU 2002349727A AU 2002349727 A AU2002349727 A AU 2002349727A AU 2002349727 A1 AU2002349727 A1 AU 2002349727A1
- Authority
- AU
- Australia
- Prior art keywords
- hepatitis
- monoclonal antibodies
- binding fragments
- virus monoclonal
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000724675 Hepatitis E virus Species 0.000 title 1
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 title 1
- 229960000060 monoclonal antibodies Drugs 0.000 title 1
- 102000005614 monoclonal antibodies Human genes 0.000 title 1
- 108010045030 monoclonal antibodies Proteins 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01134643.4 | 2001-11-08 | ||
| CN01134643 | 2001-11-08 | ||
| PCT/CN2002/000797 WO2003040187A1 (en) | 2001-11-08 | 2002-11-08 | Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002349727A1 true AU2002349727A1 (en) | 2003-07-24 |
| AU2002349727B2 AU2002349727B2 (en) | 2008-10-16 |
Family
ID=4672637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002349727A Expired AU2002349727B2 (en) | 2001-11-08 | 2002-11-08 | Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7786264B2 (en) |
| EP (2) | EP2322625B8 (en) |
| JP (3) | JP2005524386A (en) |
| KR (1) | KR101020256B1 (en) |
| CN (1) | CN100339395C (en) |
| AU (1) | AU2002349727B2 (en) |
| BR (2) | BRPI0214188B8 (en) |
| MX (1) | MXPA04004321A (en) |
| WO (1) | WO2003040187A1 (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7786264B2 (en) | 2001-11-08 | 2010-08-31 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof |
| CN1850855B (en) * | 2006-05-26 | 2012-08-29 | 厦门大学 | Method and composition for immuning or preparing monoclonal antibody |
| DK2124064T3 (en) * | 2006-12-14 | 2012-07-09 | Zhejiang Wolwo Bio Pharmaceutical Co Ltd | Method of preparing a standard serum mixture for determining the strength of an allergy and using the serum mixture |
| AR070141A1 (en) * | 2008-01-23 | 2010-03-17 | Glenmark Pharmaceuticals Sa | SPECIFIC HUMANIZED ANTIBODIES FOR VON WILLEBRAND FACTOR |
| JP5297734B2 (en) * | 2008-09-17 | 2013-09-25 | 株式会社Ｎｂｃメッシュテック | Peptide having binding ability to cedar pollen allergen |
| US8362203B2 (en) * | 2009-02-10 | 2013-01-29 | Wayne State University | Non-natural peptides as models for the development of antibiotics |
| LT2544719T (en) | 2010-03-12 | 2019-10-25 | Debiopharm Int Sa | Cd37-binding molecules and immunoconjugates thereof |
| JP6018622B2 (en) * | 2011-04-01 | 2016-11-02 | イミュノジェン， インコーポレイテッド | CD37 binding molecule and immune complex thereof |
| WO2012163289A1 (en) * | 2011-06-01 | 2012-12-06 | 厦门大学 | Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof |
| EP3744728A1 (en) * | 2013-02-12 | 2020-12-02 | Bristol-Myers Squibb Company | Tangential flow filtration based protein refolding methods |
| CN105445463A (en) * | 2014-09-25 | 2016-03-30 | 苏州新波生物技术有限公司 | Hepatitis E virus IgG antibody detection kit and preparation method and application thereof |
| MX2017015039A (en) | 2015-06-08 | 2018-08-09 | Debiopharm Int Sa | Anti-cd37 immunoconjugate and anti-cd20 antibody combinations. |
| CA2995243A1 (en) | 2015-08-28 | 2017-03-09 | Debiopharm International, S.A. | Antibodies and assays for detection of cd37 |
| EP3535297B1 (en) | 2016-11-02 | 2022-08-10 | Debiopharm International, S.A. | Methods for improving anti-cd37 immunoconjugate therapy |
| KR101940806B1 (en) * | 2017-04-21 | 2019-01-21 | (주)웅비식품 | Cutter for laver packing paper |
| CN110412267B (en) * | 2018-04-28 | 2023-04-11 | 洛阳普泰生物技术有限公司 | Canine parainfluenza virus monoclonal antibody and application thereof |
| CN112399972B (en) * | 2018-07-10 | 2024-02-06 | 国家医疗保健研究所 | Epitope of ORF2I protein of hepatitis E virus |
| ES2970072T3 (en) * | 2018-07-10 | 2024-05-24 | Inst Nat Sante Rech Med | Antibodies that have specificity for the ORF2i protein of the hepatitis E virus and uses thereof for diagnostic purposes |
| CN109913424B (en) * | 2019-03-28 | 2020-10-27 | 浙江大学 | Human liver cancer cell line containing hepatitis E virus replicon, application and construction method |
| GB201904328D0 (en) * | 2019-03-28 | 2019-05-15 | Immunocore Ltd | Specific binding molecules |
| WO2023282243A1 (en) * | 2021-07-06 | 2023-01-12 | 株式会社先端生命科学研究所 | Method for detecting hepatitis e virus infection, and antigen polypeptide and kit for detecting hepatitis e virus infection |
| WO2023174976A1 (en) | 2022-03-16 | 2023-09-21 | Universität Zu Lübeck | Broadly neutralizing antibodies against hepatitis e virus |
| CN114957411B (en) * | 2022-05-25 | 2023-08-18 | 徐州医科大学 | Recombinant protein of ORF2 of hepatitis C virus gene C1 and preparation method and application thereof |
| CN116298305B (en) * | 2023-01-03 | 2024-05-28 | 郑州大学 | Anti-NT 5C1A autoantibody detection method and in-vitro diagnostic kit |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4470925A (en) | 1982-05-05 | 1984-09-11 | E. I. Du Pont De Nemours And Company | Immunoglobulin half-molecules and process for producing hybrid antibodies |
| US4474493A (en) | 1982-09-09 | 1984-10-02 | Modular Systems, Inc. | Dowel fastener and joints including same |
| US6291641B1 (en) * | 1988-06-17 | 2001-09-18 | Genelabs Technologies, Inc. | Hepatitis E virus antigens and uses therefor |
| US5686239A (en) | 1988-06-17 | 1997-11-11 | Genelabs Technologies, Inc. | Hepatitis E virus peptides and methods |
| US5741490A (en) | 1988-06-17 | 1998-04-21 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
| US5885768A (en) | 1988-06-17 | 1999-03-23 | The United States Of America As Represented By The Department Of Health And Human Services | Hepatitis E virus peptide antigen and antibodies |
| US5219990A (en) * | 1991-01-28 | 1993-06-15 | Biogen, Inc. | Papillomavirus e2 trans-activation repressors |
| JP2908107B2 (en) | 1992-03-19 | 1999-06-21 | 株式会社日立製作所 | Solidification material for radioactive waste and method for treating radioactive waste |
| DE69334299D1 (en) * | 1992-09-18 | 2009-12-31 | Us Gov Health & Human Serv | RECOMBINANT PROTEINS OF A PAKISTANI TRIBRAY OF HEPATITIS E-VIRUS AND THEIR USE IN DIAGNOSTIC PROCEDURES AND AS VACCINE |
| US5736315A (en) | 1992-10-21 | 1998-04-07 | National Institute Of Health | Methods and compositions for detecting anti-hepatitis E virus activity |
| JP3919830B2 (en) * | 1992-11-28 | 2007-05-30 | 財団法人化学及血清療法研究所 | Anti-feline herpesvirus-1 recombinant antibody and gene fragment encoding the antibody |
| WO1995008632A1 (en) * | 1993-09-24 | 1995-03-30 | The Macfarlane Burnet Centre For Medical Research Limited | Immunoreactive antigens of hepatitis e virus |
| JP3504963B2 (en) | 1993-10-22 | 2004-03-08 | 智靖 羅 | DNA fragment encoding amino acid sequence of anti-human high affinity IgE receptor monoclonal antibody |
| CA2179494A1 (en) * | 1993-12-22 | 1995-06-29 | Deborah A. Paul | Monoclonal antibodies to hepatitis e virus and methods for using same |
| AU1437695A (en) | 1993-12-22 | 1995-07-10 | Abbott Laboratories | Monoclonal antibodies against hev orf-2 and methods for using same |
| US5830636A (en) * | 1993-12-22 | 1998-11-03 | Abbott Laboratories | HEV orf-2 monoclonal antibodies and methods for using same |
| US5830635A (en) * | 1995-03-31 | 1998-11-03 | Agnello; Vincent | Method of detecting hepatitis C virus in tissues |
| US6930176B2 (en) | 1999-12-01 | 2005-08-16 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus |
| CA2405084C (en) * | 2000-04-07 | 2011-06-14 | Howard A. Fields | Neutralizing immunogenic hev polypeptides |
| CN101367869B (en) | 2000-09-30 | 2012-12-05 | 北京万泰生物药业股份有限公司 | Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
| US7786264B2 (en) | 2001-11-08 | 2010-08-31 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof |
| JP2010053113A (en) | 2008-08-26 | 2010-03-11 | Sadanao Namiki | Self-association type magnetic lipid nanoparticles usable for drug delivery and method for producing the same |
| JP5264792B2 (en) | 2010-01-25 | 2013-08-14 | 三菱電機株式会社 | Plate heat exchanger |
-
2002
- 2002-11-08 US US10/495,091 patent/US7786264B2/en active Active
- 2002-11-08 EP EP10181815.1A patent/EP2322625B8/en not_active Expired - Lifetime
- 2002-11-08 JP JP2003542232A patent/JP2005524386A/en active Pending
- 2002-11-08 AU AU2002349727A patent/AU2002349727B2/en not_active Expired
- 2002-11-08 BR BRPI0214188A patent/BRPI0214188B8/en not_active IP Right Cessation
- 2002-11-08 EP EP02781056.3A patent/EP1452541B2/en not_active Expired - Lifetime
- 2002-11-08 BR BR122015016384A patent/BR122015016384B8/en not_active IP Right Cessation
- 2002-11-08 CN CNB028222180A patent/CN100339395C/en not_active Expired - Lifetime
- 2002-11-08 KR KR1020047007046A patent/KR101020256B1/en active IP Right Grant
- 2002-11-08 WO PCT/CN2002/000797 patent/WO2003040187A1/en active Application Filing
- 2002-11-08 MX MXPA04004321A patent/MXPA04004321A/en active IP Right Grant
-
2009
- 2009-04-30 US US12/433,497 patent/US9428554B2/en not_active Expired - Lifetime
-
2010
- 2010-03-10 JP JP2010053113A patent/JP5341799B2/en not_active Expired - Lifetime
-
2013
- 2013-04-04 JP JP2013078769A patent/JP6016699B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002349727A1 (en) | Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof | |
| EP2322625B8 (en) | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof | |
| AU2002338015A1 (en) | Human CDR-grafted antibodies and antibody fragments thereof | |
| ZA200305825B (en) | Modified antibodies and methods of use | |
| IL158643A (en) | Anti-hmg monoclonal antibodies and compositions containing the same | |
| AU2002327164A1 (en) | Engineered tetravalent antibodies and methods of use | |
| IL206832A0 (en) | Antibodies binding an 161p2f10b epitope and uses thereof | |
| HUP0400284A3 (en) | Recombinant tumor specific antibody and use thereof | |
| AU5285899A (en) | Anti hepatitis c virus antibody and uses thereof | |
| AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
| AU2002340167A1 (en) | Anti-hla-dr antibodies and the methods of using thereof | |
| IL200608A0 (en) | Methods for the detection of 193p1e1b protein and use of compositions containing a 193p1e1b protein or an antibody binding thereto | |
| AU2002332290A1 (en) | Recombinant anti-osteopontin antibody and use thereof | |
| AU2002220460A1 (en) | The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits | |
| AU2002305478A1 (en) | Conjugates of reduced antibodies and biomolecules | |
| EP1412538A4 (en) | Methods for the simultaneous detection of hcv antigens and hcv antibodies | |
| AU2002359495A1 (en) | Anti-tnf antibodies, compositions, methods and uses | |
| AU2002365228A1 (en) | Antigen panels and methods of using the same | |
| AUPR546801A0 (en) | Recombinant antibodies | |
| AU2002305028A1 (en) | West nile virus epitopes and uses thereof | |
| IL158846A0 (en) | A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same | |
| AU2002365269A8 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
| EP1432448A4 (en) | Novel molecules of the hkid-1-related protein family and uses thereof | |
| AU2002341828A1 (en) | Enhanced proteins and methods for their use | |
| AU2002342858A1 (en) | Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus |